Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors.
Gemenetzi K, Galigalidou C, Vlachonikola E, Stalika E, Xochelli A, Baliakas P, Karypidou M, Touloumenidou T, Minga E, Douka V, Iskas M, Athanasiadou A, Makris A, Stavroyianni N, Anagnostopoulos A, Hadzidimitriou A, Stamatopoulos K. Gemenetzi K, et al. Among authors: touloumenidou t. Leuk Lymphoma. 2017 Mar;58(3):726-728. doi: 10.1080/10428194.2016.1211276. Epub 2016 Aug 9. Leuk Lymphoma. 2017. PMID: 27686405 No abstract available.
Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.
Kostareli E, Hadzidimitriou A, Stavroyianni N, Darzentas N, Athanasiadou A, Gounari M, Bikos V, Agathagelidis A, Touloumenidou T, Zorbas I, Kouvatsi A, Laoutaris N, Fassas A, Anagnostopoulos A, Belessi C, Stamatopoulos K. Kostareli E, et al. Among authors: touloumenidou t. Leukemia. 2009 May;23(5):919-24. doi: 10.1038/leu.2008.379. Epub 2009 Jan 15. Leukemia. 2009. PMID: 19148139
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
Arvaniti E, Ntoufa S, Papakonstantinou N, Touloumenidou T, Laoutaris N, Anagnostopoulos A, Lamnissou K, Caligaris-Cappio F, Stamatopoulos K, Ghia P, Muzio M, Belessi C. Arvaniti E, et al. Among authors: touloumenidou t. Haematologica. 2011 Nov;96(11):1644-52. doi: 10.3324/haematol.2011.044792. Epub 2011 Jul 12. Haematologica. 2011. PMID: 21750087 Free PMC article. Clinical Trial.
Sequential transient novel chromosomal translocations in a patient with chronic myelogenous leukemia in complete cytogenetic remission after therapy with imatinib mesylate.
Papaioannou G, Athanasiadou A, Voutiadou G, Gaitatzi M, Batsis I, Touloumenidou T, Anagnostopoulos A. Papaioannou G, et al. Among authors: touloumenidou t. Cancer Genet. 2011 Dec;204(12):692-3. doi: 10.1016/j.cancergen.2011.11.004. Cancer Genet. 2011. PMID: 22285023 No abstract available.
Molecular evidence for repertoire skewing of T large granular lymphocyte proliferation after allogeneic hematopoietic SCT: report of two cases.
Papalexandri A, Stalika E, Iskas M, Karypidou M, Zerva P, Touloumenidou T, Tachynopoulou V, Batsis I, Papadaki T, Sakellari I, Anagnostopoulos A, Stamatopoulos K. Papalexandri A, et al. Among authors: touloumenidou t. Bone Marrow Transplant. 2013 Sep;48(9):1260-1. doi: 10.1038/bmt.2013.40. Epub 2013 Apr 22. Bone Marrow Transplant. 2013. PMID: 23604008 No abstract available.
ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres.
Navrkalova V, Young E, Baliakas P, Radova L, Sutton LA, Plevova K, Mansouri L, Ljungström V, Ntoufa S, Davis Z, Juliusson G, Smedby KE, Belessi C, Panagiotidis P, Touloumenidou T, Davi F, Langerak AW, Ghia P, Strefford JC, Oscier D, Mayer J, Stamatopoulos K, Pospisilova S, Rosenquist R, Trbusek M. Navrkalova V, et al. Among authors: touloumenidou t. Haematologica. 2016 Sep;101(9):e369-73. doi: 10.3324/haematol.2016.142968. Epub 2016 Jun 16. Haematologica. 2016. PMID: 27479817 Free PMC article. No abstract available.
In vitro evidence of complement activation in patients with sickle cell disease.
Gavriilaki E, Mainou M, Christodoulou I, Koravou EE, Paleta A, Touloumenidou T, Papalexandri A, Athanasiadou A, Apostolou C, Klonizakis P, Anagnostopoulos A, Vlachaki E. Gavriilaki E, et al. Among authors: touloumenidou t. Haematologica. 2017 Dec;102(12):e481-e482. doi: 10.3324/haematol.2017.174201. Epub 2017 Sep 14. Haematologica. 2017. PMID: 28912175 Free PMC article. No abstract available.
Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?
Papalexandri A, Karypidou M, Stalika E, Kotta K, Touloumenidou T, Zerva P, Paleta A, Mallouri D, Batsis I, Sakellari I, Kotsianidis I, Anagnostopoulos A, Hadzidimitriou A, Margaritis D, Stamatopoulos K. Papalexandri A, et al. Among authors: touloumenidou t. Leuk Lymphoma. 2019 Jul;60(7):1685-1692. doi: 10.1080/10428194.2018.1543881. Epub 2019 Jan 17. Leuk Lymphoma. 2019. PMID: 30652530
35 results